PharmaTimes Directors' Club - Overview
Next PDC meeting:
D-Day for NHS England– implications for Pharma and Patients
Friday 26 April, 2013, 12.30-4.00pm
The Kings Fund (off Cavendish Square, London, nearest tube Oxford Circus).
You are invited to book for the next PDC meeting, timed to attract input from senior members of the newly operational NHS England. This PDC meeting will explore the two important areas of medicines optimisation and patient care.
We are delighted that Dr Keith Ridge, who is responsible for the DH’s medicines optimisation strategy, and Tim Kelsey, the new NHS England national director for patients and information, will be speaking at the meeting. Both are likely to have a significant influence on the future management of medicines optimisation and patient care pathways, and patient outcomes.
Also joining us will be one of the new CCG leads, Dr Caron Morton, chair of Shropshire CCG who will give us insights from a CCG perspective on how NHS England will drive change at local level.
|The agenda can be viewed here: || |
|Please book here: || |
PDC is a unique, informal, networking forum for UK pharmaceutical company directors to meet three times a year to focus on 'member-chosen' industry issues.
PDC operates under the Chatham House Rules.
The meeting topics are selected by the PDC steering group and then finalised by Member ballot.
PDC frequently is the first industry forum to gather experts to discuss the latest news breaking topic.
PDC has organised three meetings a year since 1989, thus providing a regular and dependable forum for industry directors.
PDC attracts top speakers who value the opportunity to share their views with the industry's leaders.
For members, the presentation slides are made available electronically (most occasions).
- A personal copy of PharmaTimes Magazine is offered to all Member employees.
- Free access to the popular www.pharmatimes.com (64,200 unique users for 20 March to 20 April) and daily World News elert service is offered to all PDC Members and their employees, plus free access to the PharmaTimes 20,000+ News archive.